AV8 Ventures
555 Bryant St. Suite #201, Palo Alto, CA, 94301, United States
Overview
They bring decades of experience with a hands-on approach to working closely with start-ups. Their investment and support team leverages deep technical, entrepreneurial and venture experience to help their companies succeed. Their network includes some of the brightest minds in health, machine learning, enterprise technology, mobility, robotics, hard sciences and biology.
- Total investments
- 41
- Lead investments
- 12
- Investments · 12mo
- 2
- Active investors
- 7
Sector focus
- Enterprise Software
- Financial Services
- FinTech
- Health Care
- Venture Capital
Investment portfolio
- Flourish Health
Participated · Series A · Jul 2026
Flourish Health delivers intensive in-home mental health care for children and young adults through psychiatrist-led Care Pods composed of a child and adolescent psychiatrist, a licensed therapist, a patient guide, and a family guide. The company built a proprietary technology platform that integrates patient touchpoints, EMR and prescribing capabilities, workflow automation, team collaboration, and AI to support engagement and coordination while clinicians make clinical decisions. Flourish specializes in three clinical populations: children with externalizing behaviors, young people with multiple suicide attempts or suicide-related hospitalizations, and patients with complex needs and family situations often turned away by other clinics. Studies run with multiple major health plans report large reductions in hospitalization (70–96%), residential treatment (69–90%), and sustained decreases in higher levels of care post-discharge (80–95%). Flourish commits to beginning care within one week of referral, reports 92% month-over-month retention during its 12-month programs, and says those programs cost less than one month of inpatient treatment.
- Think Bioscience
Participated · Series A · Jan 2026
Think Bioscience leverages a proprietary synthetic biology platform to identify previously hidden binding pockets on proteins that have long been considered undruggable. By coupling high-throughput functional surveys with protein biophysics, enzymology, and computational chemistry, the company designs first-in-class small molecules across a wide array of target classes, including transcription factors, phosphatases, kinases, proteases, and GTPases. Its lead program addresses mutant proteins that drive Noonan syndrome, a genetic disorder affecting roughly 1 in 2,500 births and currently lacking disease-modifying therapies. Beyond this flagship effort, the company is advancing a “robust internal pipeline” of additional programs built on the same discovery engine. The new Series A financing brings in significant capital to expand these programs and further validate the platform. Think Bioscience remains privately held and has not disclosed revenue or patient enrollment metrics to date.
- Hydrolix
Participated · Series C · Apr 2025
Hydrolix builds a streaming data lake platform that combines stream processing, decoupled storage, high-density compression and indexed search to enable real-time queries on large volumes of log data. The platform targets log-intensive use cases including security, observability, content delivery, adtech, AI/ML and regulatory compliance. Hydrolix has leaned into channel partnerships—notably a white‑label TrafficPeak offering with Akamai—and added AWS as a go-to-market partner while building connectors for ecosystems like Splunk, Databricks and Kibana. The company says it added 400+ customers in the past year, posted an eightfold sales increase year-over-year, and now earns more than 40% of revenue from international customers. Future plans for the funding include extending availability to additional cloud platforms, expanding the types and sources of data ingested, and amplifying sales momentum through regional partners and vertical expertise. Hydrolix builds a streaming data lake platform that provides a repository for log data and delivers that data to applications in real time. Its technology combines real-time stream processing, decoupled storage and low-latency indexed search to enable high-performance, cost-efficient log management. Hydrolix keeps all data “hot,” avoiding multiple storage tiers and claiming real-time query performance at terabyte scale. The platform powers log-intensive use cases across security, observability, AI/ML and sectors such as advertising, travel and retail, and can run on customers’ cloud infrastructure or as a partner data layer. Hydrolix reported annual recurring revenue of roughly $6 million, doubled revenue from Q3 to Q4 2023 and grew another 75% in Q1 2024; it serves about 90 customers and has a Portland, Oregon–based workforce of around 60. The company plans to scale its sales and partner channel operations as well as marketing and customer onboarding following the new funding. Hydrolix provides a real-time data platform designed to store and query logs, traces and metrics at much lower cost. It uses a custom storage layer that delivers SSD-like performance using cloud object storage and diskless spot instances, enabling fully indexed search without caching or bulk column scans. The architecture targets livestream ingest and ad-hoc data exploration workloads that traditional analytics systems struggle with. Hydrolix is currently compatible with AWS and offered through the Amazon Marketplace; versions for Azure and Google Cloud are expected later this year. The company was founded at the end of 2018, is headquartered in Portland, Oregon, and has about 20 employees spread across six countries. Investors and the company emphasize that the product eliminates common trade-offs between retention cost and query performance.
- CoverTree
Participated · Series A · May 2024
CoverTree builds digital distribution, automated underwriting, and data-driven pricing specifically for manufactured-home insurance. Its core product is a manufactured-home insurance offering available across multiple U.S. states, and the company emphasizes transparency, simplicity, and personalization. CoverTree is expanding beyond consumer policies into an enterprise suite that will include Maple (resident insurance management software for property managers), Bonsai (a binding and underwriting platform for independent agents and lenders), and Sequoia (an automated underwriting and quoting system for insurance book conversions). The company says its distribution technology can reach manufactured-home residents in relatively rural parts of the U.S. without running marketing ads. CoverTree highlights a large addressable market with over 22 million Americans living in manufactured homes and notes that 11% of new single-family homes in 2022 were manufactured homes. The company is headquartered in Detroit, Michigan, and its manufactured-home product is available in Arizona, Michigan, Indiana, New Mexico, Ohio, Illinois, Tennessee, Texas, Arkansas, South Carolina, Kansas, Oklahoma, Georgia, and Alabama. CoverTree is an insurtech MGA focused on bringing digital distribution, automated underwriting, and data-driven pricing to specialty personal lines with an initial focus on manufactured homes. The company has launched its manufactured home product in Arizona, Indiana, Michigan, New Mexico, Ohio, Illinois, and Tennessee. CoverTree built its program in close collaboration with Markel, with coverage provided by Markel Insurance Company, and emphasizes building proprietary data sets and automated underwriting to address sparse data in the segment. The company plans to use recent funding to grow the team, expand into additional states and product lines, invest in distribution portals, and further automate underwriting. CoverTree positions itself to modernize an underserved market and to support rural and outdoor lifestyles through a full digital insurance experience.
- Cerby
Participated · Series A · Aug 2023
Cerby builds an identity automation platform that secures disconnected applications by integrating with IAM, IGA, PAM and EPM systems to automate credentials, authentication, lifecycle management, and privileged access. The platform works horizontally across enterprise identity domains to extend protection to applications traditional tools can't reach and now automates workflows across more than 2,000 applications. Cerby supports over 100 organizations worldwide, including customers such as L'Oréal, Fox, Allstate, Chime, and Dentsu. Since its Series A less than 20 months ago the company has 10x'd ARR and grown its customer base 5x. Cerby plans to use new capital to expand the Cerby Application Network, invest in agentic AI capabilities, and make the platform more extensible. It will also scale go-to-market operations in North America and EMEA, prioritizing Germany, France, the UK and strategic Middle Eastern regions. Cerby provides a platform that integrates nonstandard applications into a unified identity mesh by harnessing upstream identity providers (e.g., Okta, Azure AD, SailPoint) to automate onboarding, offboarding and MFA enrollment. The product gives security teams visibility and control over employee‑onboarded apps, enables shared access without password sharing, and detects rogue apps while guiding users to safer alternatives. Cerby’s customers span departments (marketing, sales, product, manufacturing, finance) and application types (on‑prem, OT, legacy, cloud). The company plans to adopt large language models to improve threat detection and offer in‑context guidance for secure app configuration. Cerby says it has about 60 employees and 26 active customers, including Colgate‑Palmolive and a “major” healthcare provider. The firm competes with vendors like Nudge Security and Strata Identity and intends to use new funding to scale go‑to‑market, sales and marketing and to pursue federal customers in late 2024. Cerby provides enterprises a registration and automation platform for apps not managed by IT, enabling users to register apps, add permissions, and automatically identify and remediate security gaps. The platform is aimed at securing decentralized remote working environments by encouraging app registration so applications can be audited and secured. Cerby differentiates by automating the complete lifecycle of non-IT-managed apps—rotating passwords, enrolling two-factor authentication, removing users, and disabling noncompliant settings—without relying on manual work from IT or end users. CEO and cofounder Belsasar Lepe said about half of workplace apps are purchased by non-IT buyers and that Cerby helps detect and auto-secure these apps. The company plans to use the new funding to grow commercial and customer-success teams and expand its library of integrations to support the top 5,000 most commonly used apps. Cerby competes in the broader security automation/SOAR space and aims to move automation capabilities beyond IT teams into the hands of general employees. Cerby builds security tools to help enterprises embrace and control Shadow IT, with an initial focus on securing how end users share credentials. The company’s product targets scenarios where credential sharing conflicts with traditional enterprise systems and security best practices. Cerby is helping news organizations and political campaigns control how distributed teams access corporate and brand accounts. The 15-person team is fully remote, with members located across the U.S. and Mexico. Cerby is in closed beta with select Fortune 1000 customers and will use funding to accelerate product development and hiring.